Manzana Postobon triggers UCI’s team suspension rule after second positive test

Don’t miss out on the latest CyclingTips updates.

Jump To Comments

Colombian outfit Monzana Postobon faces a suspension of 15 to 45 days after triggering a UCI regulation that requires the suspension of any team with two adverse analytical findings (AAFs) within 12 months, according to a UCI statement.

Juan José Amador’s positive A sample for Boldenone, an anabolic steroid, made him the second rider from the team to return an AAF in the last year. The first was Wilmar Paredes, who was notified of an EPO positive in February 2019. Amador is provisionally suspended but has the right to request a test of his B sample.

The UCI has handed the matter to its Disciplinary Commission, which will determine the start date and length, from 15 to 45 days, of the team’s suspension. Manzana Postobon is currently scheduled to take the start the Tour de l’Ain on Friday.

The UCI used the same press release to announce that another Colombian rider, Alex Cano, was notified of an Anti-Doping Rule Violation (ADRV) based on abnormalities in his biological passport. Cano, who rides for the Continental team Coldeportes Zanu, has been provisionally suspended until his case is adjudicated.

Manzana Postobon was founded in 2006 and primarily races in South America, though it has done stints in Europe and Asia. It became a Pro Continental team in 2011 as Colombia es Pasión-Café de Colombia, but has since returned to the Continental level. It has graduated WorldTour riders like Sergio Henao (UAE Team Emirates) and Jarlison Pantana, who rode for Trek-Segafredo until he returned an AAF for EPO and was released from the team in April, 2019. Pantano remains provisionally suspended.

Editors' Picks